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Basal cell carcinoma (BCC) incidence rates are increasing. From 1973 to 2009, data on all first histologically
confirmed BCCs were gained from the Eindhoven Cancer Registry to estimate trends in patient-based BCC
incidence rates by sex, age group, and site in the southeast Netherlands. Trends in European age-standardized
rates and age- and site-specific incidence rates were assessed by calculating the estimated annual percentage
change (EAPC). Between 1973 and 2009, the European standardized rate quadrupled from 40 to 165 per 100,000
person-years for men and from 34 to 157 for women, significantly increasing since 1973 in both sexes, but
accelerating from 2002 until 2009 with an EAPC of 6.8% (95% confidence interval (CI), 5.3–8.3) for men and 7.9%
(95% CI, 6.2–9.7) for women. Women below the age of 40 years exhibited a constant linear increase of 6.3% since
1973. The head and neck region was most often affected in both sexes, but the steepest increase was seen for the
trunk (EAPC men 13%, women 15%). In the absence of reliable tumor-based rates, these alarming patient-based
rates are probably an interesting indicator for the impact of more intensive UV exposure in a prosperous
European population.
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INTRODUCTION
The incidence rates of UV-induced skin cancers, including
basal cell carcinoma (BCC), are increasing worldwide and are
becoming a major public health concern (Bath-Hextall et al.,
2007; Birch-Johansen et al., 2010; Holterhues et al., 2010;
Flohil et al., 2011a). Mortality rates associated with BCC are
low (o0.1%), but localized tissue invasion may induce
considerable functional and cosmetic morbidity, especially
because the majority of the lesions are located on the face
(Hannuksela-Svahn et al., 1999; Lewis and Weinstock, 2007;
Jensen et al., 2008). Only few cancer registries record BCC,
and in most cases only the first histologically confirmed BCC
per patient is included (Bath-Hextall et al., 2007; Birch-
Johansen et al., 2010; Flohil et al., 2011a). This is mainly
because of the large number of tumors involved and its
associated costs.
In general, BCCs are considered a disease of the elderly
(Karagas et al., 1999; Bath-Hextall et al., 2007; Flohil et al.,
2011a). However, a recent large Danish population-based
study between 1978 and 2007 showed that the average
percentage change in BCC incidence was significantly
higher among those younger than 40 years than in older
persons, especially in women (Birch-Johansen et al., 2010;
Flohil et al., 2011a). This was in accordance with most other
studies reporting a trend toward higher increase in BCC
incidence in younger persons (de Vries et al., 2004;
Christenson et al., 2005; Bivens et al., 2006). For squamous
cell carcinoma (SCC) and melanoma, similar increases in rates
have been observed for younger persons (Purdue et al., 2008).
An increase in the number of BCC patients, especially in
younger age groups, may lead to an exponential rise in the
overall occurrence of BCC over time, particularly because the
population ages and most likely around 30% will develop
subsequent BCCs within 5 years (Flohil et al., 2011b).
A previous study of the BCCs registered in the Dutch Eindhoven
Cancer Registry (ECR) from 1973 until 2000 observed significant
and consistent increases in BCC rates for both sexes (Coebergh
et al., 1991; de Vries et al., 2004). The objective of this study was
to investigate potential changes in trends in the increasing BCC
incidence rates by age and site in the southeast Netherlands
(latitude 511 north), using up-to-date ECR data until 2009.
RESULTS
Age-standardized incidence rates
Between 1973 and 2009, first histologically confirmed 52,831
BCCs were registered in 52,831 patients recorded in the ECR,
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corresponding to 26,155 (49.5%) men and 26,676 (50.5%)
women. During this 37-year period, the age-standardized
incidence rates increased approximately fourfold for both
men and women, respectively, from 40 to 165 and 34 to
157 per 100,000 person-years (Figure 1 and Table 1).
The highest relative increase in rates (12-fold) was found in
women below the age of 40 years, with an increase from 1.82
to 22.2 per 100,000 persons-years, followed by women aged
between 40 and 64 years (Table 1). For men, this was
observed within the oldest age group (4.4-fold), whereas
women in this age group had the lowest increase (3-fold)
over time.
For all body sites, the age-standardized BCC incidence rates
increased significantly between 1973 and 2009. In 2009, the
head and neck region was most often affected in both men
and women (99.2 and 85.5 per 100,000 persons-years,
respectively). More than 58% of the total number of newly
diagnosed BCCs (n¼ 4 511) in 2009 was located within the
head and neck region. However, during the 37 years of
observation, the highest relative increase in rates was found
on trunk in men (77-fold), followed by legs (32-fold) and trunk
(25-fold) in women (Table 1).
Trends by age
Since 1973, a significant increase in patient-based incidence
rates was observed with joinpoint analyses for men and
women, 2.3% and 3.9%, respectively (Table 2). Around the
years 2002 to 2003 until 2009, this trend accelerated, which
resulted in a more-than-doubled annual percentage change
(EAPC) of 6.8% for men and 7.9% for women. Men within the
youngest age group had no significant increase in BCC
incidence from 1973 to 1985, whereas after that period the
EAPC rose to 4.5% (95% confidence interval (CI), 3.3–5.8).
For women below the age of 40 years, no joinpoint was
observed between 1973 and 2009, resulting in an annual
linear increase of BCC incidence of 6.3% from 1973 to 2009
(Figure 2). From 1973 onward, the BCC incidence of men and
women in the age groups 40–64 and X65 years increased
steadily over time, with EAPCs ranging from 2.3 to 4.6%
(Figure 2). Around the years 2002–2004, this pattern signifi-
cantly altered according to the joinpoint analysis and trends in
BCC incidence accelerated, with the highest EAPC of 7.9%
(95% CI, 5.2–10.6) found in women aged between 40 and 64
years (Table 2).
Trends by site
All body sites exhibited significant increases in BCC rates,
except for the lip in men (Table 2). The head and neck region
was the most commonly affected site for BCC during the
whole study period, but showed the lowest annual increase in
rates per year (4.7% in men and 5.8% in women). In the
last 4–6 years before 2009, steep increases were especially
seen for BCC on the trunk in men (EAPC 12.8%) and women
(EAPC 14.8%). From 1998 onward, a similar acceleration in
rates was observed for BCCs on arms in men. For BCC located
on the legs, there was a constant linear increase in rates
(Table 2).
BCC cumulative risk
In 2009, the cumulative risk for developing a first histologi-
cally confirmed BCC before the age of 40 years was higher in
women (0.9%) than in men (0.4%), corresponding to 1 in 112
and 1 in 250, respectively. When expanding the risk set to 65
years, again women were more often affected by BCC than
men (7.0% (1 in 14) vs. 5.5% (1 in 18)). However, the lifetime
BCC risk for men was approximately 1 in 5 (21%) and for
women it was 1 in 6 (18%).
DISCUSSION
In 2009, more Dutch citizens were newly diagnosed with
BCC than with any other cancer (http://cijfersoverkanker.nl/,
180
160 ESR, menESR, women
140
120
ES
R 
pe
r 1
00
,0
00
 p
er
so
n-
ye
a
rs
100
80
60
40
20
0
1970 1975 1980 1985 1990
Year
1995 2000 2005 2010
Figure 1. Age-standardized incidence rates (European standardized rates
(ESR)) from 1973 to 2009 of the first, histologically confirmed basal cell
carcinoma in the southeast Netherlands by men and women.
Table 1. Age-standardized incidence rates (ESR) by age
and site from 1973 to 2009 of first, histologically
confirmed BCC in the southeast Netherlands
ESR, men ESR, women
1973 2009 1973 2009
Age (years)
All 40.2 164.7 34.4 157.3
o40 2.4 9.9 1.8 22.2
40–64 53.9 203.1 35.4 242.8
X65 196.6 854.6 199.6 608.8
Site
Head/neck 37.7 99.2 28.5 85.5
Trunk 0.5 38.7 1.7 41.7
Arms 1.4 15.0 1.8 12.5
Legs 0.5 8.5 0.4 12.8
Lip 0.0 2.4 1.4 4.2
Abbreviations: BCC, basal cell carcinoma; ESR, European standardized
rates.
ESR expressed per 100,000 persons-years.
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accessed 15 March 2012). Elderly people were most often
affected by BCC, but increases in BCC occurrence were
steepest among young women, which is in line with other
observational studies (Christenson et al., 2005; Birch-Johansen
et al., 2010). Between 1973 and 2009, women aged 40 years
or less showed the most rapid increase in BCC rates compared
with other age groups. Young women were also the only
subgroup with a high constant linear increase in BCC rates
over the past 37 years. Since 2002, accelerations in the speed
of increase of incidence were also noted among older women
and in men.
The continuous increment was not restricted to BCC
incidence. The melanoma and SCC incidence increased
significantly in young people, but this is even more pro-
nounced in the elderly (Purdue et al., 2008; Jemal et al.,
2011). In accordance with previous studies, BCCs were
predominantly located in the chronically UV-exposed head
and neck region (Scrivener et al., 2002; Flohil et al., 2011b).
However, the steepest acceleration in site-specific BCC rates
was detected on the trunk, most likely due to more frequent
intermittent UV exposure (e.g., more people traveling,
wearing a bikini, and practicing outdoor activities) of
otherwise covered body parts (Randle, 1997).
Accelerating increase in BCC rates
From 2002 onward, we observe an acceleration in the
increase in BCC rates. Interestingly, we also observed a
joinpoint for SCC trends in the same year with an EAPC of
9.2% for women and 6.9% for men (Hollestein et al., 2012),
but not in trends of melanoma incidence using nationwide
cancer registry data (Holterhues et al., 2010). This deviation
from the trend in incidence of keratinocyte carcinomas (BCC
and SCC) may be due to several factors. An increased
awareness of cutaneous malignancies in the general popula-
tion due to skin cancer prevention campaigns may have led to
more skin checks and diagnoses of previously undiagnosed
keratinocyte carcinomas. In addition, the number of practicing
dermatologists in the ECR region may have increased. This,
together with the fact that clinicians are more aware of skin
cancer and more often perform full body skin examinations,
increases the likelihood of keratinocyte carcinomas being
diagnosed (Bastiaens et al., 1998; Valery et al., 2004). The
fact that the most marked increase in incidence is on the trunk
is also consistent with increased surveillance as suggested
previously (Valery et al., 2004). Although the rise in mela-
noma incidence can partly be explained by overdiagnosis
through improvement of histological diagnostic criteria, this is
probably not the case for BCC (Weyers, 2012). An increased
detection rate of BCC in cancer registries based on pathology
reports may also be induced by changes in health-care
organization and/or reimbursement of care. The joinpoint for
BCC was observed in 2002; however, market forces were
introduced much later in the Netherlands, namely in 2006,
stimulating Dutch clinicians to treat non-life-threatening BCCs
more rigorously than before (e.g., surgical excision instead of
cryotherapy, curettage, electro-dissection, or a wait-and-see
policy in elderly with multiple comorbidities). This resulted in
more histopathologically confirmed BCCs. It is unlikely that
improved processes within the registry resulted in a higher
capture rate and explain the changes in BCC and SCC
incidence, as there is substantial continuity in the registra-
tion staff (personal communication ECR). The demographic
changes in the Dutch population (i.e., gender and age) were
adjusted for in the analyses and, therefore, cannot explain the
increase in BCC either. In fact, the proportion of people with
dark skin, protective of skin cancer, increased during the study
Table 2. Time trends in age- and site-specific incidence rates of BCC among men and women in the southeast
Netherlands from 1973 to 2009
Men Women
Trend 1 Trend 2 Trend 1 Trend 2
Years1 EAPC (95% CI) Years EAPC (95% CI) Years EAPC (95% CI) Years EAPC (95% CI)
Age (years)
All 1973–2002 2.3 (2.0–2.7) 2002–2009 6.8 (5.3–8.3) 1973–2003 3.9 (3.5–4.2) 2003–2009 7.9 (6.2–9.7)
o40 1973–1985  2.4 ( 9.6–5.5) 1985–2009 4.5 (3.3–5.8) 1973–2009 6.3 (5.6–7.0)
40–64 1973–2003 2.4 (1.9–2.7) 2003–2009 6.4 (4.4–8.5) 1973–2004 4.6 (4.2–5.1) 2004–2009 7.9 (5.2–11)
X65 1973–2002 2.3 (1.9–2.8) 2002–2009 7.5 (5.8–9.3) 1973–2002 2.6 (2.1–3.1) 2002–2009 7.8 (6.1–9.6)
Site
Head/neck 1973–2003 1.6 (1.2–1.9) 2003–2009 4.7 (2.3–7.1) 1973–2004 2.8 (2.4–3.1) 2004–2009 5.8 (2.8–8.8)
Trunk 1973–2003 5.6 (4.6–6.5) 2003–2009 12.8 (8.8–17) 1973–2005 7.8 (7.0–8.5) 2005–2009 15 (9.4–21)
Arms 1973–1998 4.2 (2.5–6.0) 1998–2009 11.2 (9.0–13) 1973–2009 8.7 (8.0–9.5)
Legs 1973–2009 8.1 (6.9–9.4) 1973–2009 7.8 (7.0–8.6)
Lip 1973–2009 0.5 ( 0.8–1.9) 1973–2009 3.2 (2.3–4.1)
Abbreviations: BCC, basal cell carcinoma; CI, confidence interval; EAPC, estimated annual percentage change within joinpoint segment.
1Period in years within joinpoint segment.
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period, which would, in theory, lead to dilution of risk (Rubin
et al., 2005; Kiiski et al., 2010; http://www.cbs.nl/, accessed
15 March 2012). The most plausible explanation is increased
UV exposure due to outdoor leisure activities and sports since
the 1950s when weekly working hours were reduced and the
number of holidays were increased (Randle, 1997). In the
early 1980s, air travel became less expensive and more
accessible to the general Dutch population, encouraging
people to travel to sunny destinations (http://www.cbs.nl/,
accessed 2 July 2012). Furthermore, in the past decade,
sunbed use has increased markedly, particularly in younger
populations (Levine et al., 2005). In the Netherlands, the
popularity of sunbed use started around 1990, but regulatory
changes have only been introduced recently.
Implications
Knowledge about sun protective behavior is considered to be
relatively good among the European population, but informing
people about adverse effects (of the sun) does not necessarily
induce changes in risk behavior (Peacey et al., 2006; Paul
et al., 2008; Suppa et al., 2012), because despite multiple
prevention campaigns the ‘‘knowledge-behavior gap’’ remains
(Garbe and Buettner, 2000; Devos et al., 2003; Schneider
et al., 2009; Flohil et al., 2011a; Jones et al., 2012; Suppa
et al., 2012). Therefore, more effective interventions focused
on specific subgroups of the populations to influence skin
cancer risk behavior should be explored. More strict
legislations should be considered, for example, restricting
sunbed use to persons aged 18 years or older (http://
www.vwa.nl/, accessed 15 March 2012). The growing
number of skin cancers will place increasing demands on
health-care providers, i.e., more dermatologists, nurse
practitioners, and physician assistants specialized in skin
cancer may be required. In addition, general physicians and
(plastic) surgeons might wish to be more informed about the
diagnosis and treatment of cutaneous (pre)malignancies.
Moreover, the fast-growing number of (young) BCC patients
emphasizes the need to increase skin cancer awareness
among all clinicians to improve the case-finding strategy
among those involved in skin cancer care (e.g., general
practitioners, dermatologists, and (plastic) surgeons). BCCs
should be part of the differential diagnosis in persistent solitary
skin lesion even in younger persons.
Strengths and limitations
The ECR reports the first histologically confirmed BCC per
patient, ignoring BCCs that were clinically diagnosed and
treated without histological confirmation. Therefore, the inci-
dence rates provided within this study are probably an
underestimation of the true BCC incidence. The degree of
underestimation is likely to be small, as a previous Dutch
study observed that 7% of all subsequent BCCs in patients
with prior BCC were not histologically diagnosed (Flohil et al.,
2012a,b). Unfortunately, there is no information available on
the proportion of nonhistologically diagnosed BCC before this
study of 2012.
It was assumed that the age-standardized BCC rates calcu-
lated with population-based data from the ECR were repre-
sentative for the Netherlands as a whole (Flohil et al., 2011a),
although other demographic factors such as socio-economic
status and ethnicity that affect BCC risk may vary across the
country. However, age-standardized incidence rates of
melanoma, based on nationwide data from 2009, differed
only slightly from the rates calculated with data from ECR
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Figure 2. Joinpoint regression lines based on basal cell carcinoma age-
standardized incidence rates (European standardized rates) from 1973 to
2009 in the southeast Netherlands. (a) Men and women aged o40 years.
(b) Men and women aged 40–64 years. (c) Men and women aged X65 years.
CI, confidence interval; EAPC, estimated annual percentage change (within
joinpoint time segment); ESR, European standardized rate.
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(22.8 vs. 19.6, respectively), indicating a minor under-
estimation when extrapolating our BCC estimates (http://
cijfersoverkanker.nl/, accessed 15 March 2012).
The nonsignificant trend in rates observed among men aged
below 40 years from 1973 to 1985 is probably because of the
small number of men with BCC in this age category during
that period.
Conclusion
In addition to the continuous increase in BCC incidence rates,
an alarming acceleration in BCC rates was observed after
2002 in the southeast Netherlands. Besides emphasizing the
need for effective primary preventative skin cancer strategies,
these results are a warning to our society. Governments,
together with health professionals, need to respond more
actively and differently to this ‘‘BCC epidemic’’ to stabilize
and ultimately decrease BCC rates in the future.
MATERIALS AND METHODS
Data collection
For BCC incidence, we used patient-based data from ECR, which is
part of the Netherlands Cancer Registry and located at the Compre-
hensive Cancer Centre South. ECR is the only population-based
cancer registry in the Netherlands that routinely registers the first,
histologically confirmed BCC per patient using PALGA, the nation-
wide network and registry of histopathology and cytopathology, as a
signaling source (Casparie et al., 2007; Flohil et al., 2011a). PALGA
contains all excerpts of pathology reports and has nationwide
coverage since 1991, based on all Dutch laboratories, which gave
their excerpts to the cancer registry (Casparie et al., 2007). In this
study, all individuals with a first, histologically confirmed BCC
diagnosed between 1973 and 2009 were obtained from ECR (Fritz
et al., 2000). During this period (1 January 1973 to 1 January 2010),
primarily because of expansion of the registry area, the number of
inhabitants within the ECR catchment area increased from 591,916 to
2,261,967 (Coebergh et al., 1991).
Statistical analysis
First, the crude incidence of the first histologically confirmed BCC per
patient was calculated. Numbers of BCC cases, subdivided by sex
and eighteen 5-year age groups (0–4, 5–9, 10–15, and so on), were
divided by the number of inhabitants in the ECR catchment area in
these same categories. Furthermore, age-standardized incidence rates
were calculated for sex by age group and site by direct standardiza-
tion to the European Standard Population (European standardized
rates), expressed per 100,000 person-years (Flohil et al., 2011a).
The BCC site was coded according to the International Classifica-
tion of Diseases for Oncology-3 and categorized into head and neck,
trunk, arms, legs, lips, and other (Fritz et al., 2000). Given the small
number of BCC cases within the category ‘‘other’’, these data have
not been reported in this study. ‘‘Age’’ at the date of first histologically
confirmed BCC was (a priori) subdivided into three groups:o40
years, 40–64 years, and X65 years.
Trends in BCC incidence rates were assessed by calculating the
EAPC and the corresponding 95% CI, with the joinpoint regression
model. The latter identifies the year in which a significant change in
rates occurred (Kim et al., 2000; Purdue et al., 2008). To calculate
this, a regression line was fitted to the natural logarithm of the rates,
using the calendar year as a regressor variable (i.e., y¼ axþ b, where
y¼ ln(rate) and x¼ calendar year, then EAPC¼ 100 (ea 1)).
Trends in incidence rates were described for site and age group by
sex. Statistical analyses were performed with Joinpoint version
3.5.2 obtained from the National Cancer Institute (http://
surveillance.cancer.gov/joinpoint).
The cumulative risk of developing a BCC before ages 40, 65,
and 85 years (the latter considered as BCC lifetime risk) was
calculated for the year 2009. First, the cumulative incidence rates
of BCC occurrence before ages 40, 65, and 85 years were calculated
as the sum of the sex- and age-specific incidence rates for ages 0–39,
0–64, and 0–84 years, respectively, and multiplied by the width of the
age groups (5 years). Thereafter, cumulative risks were calculated
from the cumulative incidence rates using the following
formula: cumulative risk¼ 100 (1 exp (cumulative rate/100);
Flohil et al., 2011a).
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